Matthew R. Lewin holds a PhD degree in neurophysiology and is Board certified in the field of emergency medicine. He is a Fellow at the California Academy of Sciences as well as the American College of Emergency Physicians. Lewin recently served on the World Health Organization Snakebite Envenoming Working Group Antidotes Committee. He earned his BSc in entomology from the University of California, Berkeley and MD and PhD at the University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences where he was the 2020 Distinguished Alumni. He is Director of the California Academy of Sciences Center for Exploration and Travel Health and is founder of the Public Benefit Company, Ophirex, Inc. developing lifesaving antidotes for neglected tropical diseases such as snakebite envenoming. Addressing the unmet needs of early diagnosis and intervention od Parkinson’s disease and acute neurological injury from snake bites is the overarching theme of Lewin’s teaching and research programs. He was the recipient of the 2017 UCSF John L. Ziegler Outstanding Mentorship in Global Health Sciences Award.